Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

BLa80 and LRa05 probiotics and blood metabolite changes in healthy adults

Official title: Effects of BLa80 and LRa05 on the Gut Microbiota Metabolite Profile of Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial

Run by Wecare Probiotics Co., Ltd. · NCT07287306 · Data updated 2026-11-12

This test will see if taking the probiotics BLa80 or LRa05 changes how healthy adults break down and absorb food, as shown by metabolites in the blood.

More Healthy Individuals trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment375 (estimated)
SponsorWecare Probiotics Co., Ltd.
Industry-sponsored
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedDecember 10, 2025
Main results expectedJune 20, 2026
Study endsNovember 15, 2026
Registry record updatedDecember 17, 2025
Trial IDNCT07287306 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults 18–60 who can give written informed consent and who have not taken antibiotics or probiotics in the prior 3 months are ideal candidates.

Probably not a fit

People with gastrointestinal disease, recent antibiotic or probiotic use, major metabolic, immune, cardiac, liver, neurological, or psychiatric disorders, pregnant or breastfeeding women, or those on immunosuppressants are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study enrolls healthy adults aged 18–60 and assigns them to receive BLa80, LRa05, or placebo. Blood samples will be analyzed using metabolomics to identify food-derived metabolites and compare changes between groups. Key exclusions include recent antibiotic or probiotic use and major gastrointestinal, metabolic, immune, cardiac, liver, neurological, or psychiatric conditions. The research requires in-person visits at The First Affiliated Hospital, Sun Yat-sen University for dosing and sample collection.

Why it matters

Potential benefit: If successful, the probiotics could improve breakdown and absorption of dietary compounds and increase beneficial blood metabolites.

How similar studies have gone: Some prior studies have shown that specific probiotic strains can alter gut metabolite profiles, but effects are strain-dependent and not consistently reproduced.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female participants aged 18 to 60 years;
2. Healthy individuals;
3. Participants must provide written informed consent.

Exclusion Criteria:

1. History of gastrointestinal surgery, other gastrointestinal diseases, metabolic disorders, immunodeficiency, hyperthyroidism, or cardiac or liver disease;
2. Use of immunosuppressants;
3. Pregnant or breastfeeding women;
4. Participants who have taken antibiotics or probiotics within the previous 3 months;
5. Planned surgery during the study period;
6. Patients with neurological disorders or psychiatric illness.

Where it's running

  • The First Affiliated Hospttal, Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.